Study Review Sample Clauses

Study Review. Research conducted by the Principal Investigator at General shall be with the prior approval and ongoing review of all appropriate and necessary review authorities and in accordance with all applicable federal, state and local laws and regulations. Principal Investigator shall, when applicable, provide Palomar with written evidence of review and approval of Clinical Studies prior to initiation of the Clinical Studies and shall inform Palomar of the IRB’s continuing review promptly after such review takes place, which shall be at least once per year. All volunteers shall meet the legal age requirements of the Commonwealth of Massachusetts, the state in which the Research is to be conducted. In the performance of this Agreement, General agrees not to provide Palomar with any patient identifying information. Recognizing a common goal of securing the integrity of all individually identifiable health information, the parties agree to treat as confidential all individually identifiable health information in accordance with all applicable federal, state and local laws, rules and regulations governing the confidentiality and privacy of individually identifiable health information, including, but without limitation, to the extent that each party is subject to it, the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) and any regulations and official guidance promulgated thereunder. Palomar further agrees, at all times, to regard and preserve as confidential such individually identifiable health information, and to refrain from publishing or disclosing any part of such individually identifiable health information or from using it, except as necessary to discuss and analyze the results of the study, to ensure research integrity, to communicate with the Food and Drug Administration and other regulatory authorities, and otherwise as required by law or as permitted by authorizations or consents signed by study subjects or waivers of authorization granted by an IRB overseeing the study or General’s affiliated Privacy Board (the “Permitted Activities”). Palomar also agrees to restrict the use and disclosure of any individually identifiable health information gained through the Permitted Activities to its workforce, contractors, subcontractors, study collaborators and agents (collectively “Recipients of Patient Information”) who must have access to that information in order directly to support or facilitate the Permitted Activities; and to notify the Rec...

Study Review. Principal Investigator shall conduct the Study at General with the prior approval and ongoing review, of all appropriate and necessary review authorities and in accordance with all applicable federal, state, and local laws. and regulations. Principal Investigator shall provide Company with written evidence of review and approval of this Study by General's Institutional Review Board ("IRB") prior to the initiation of the Study and shall inform Company of the IRB's continuing review promptly after such review takes place, which shall be at least once per year. All volunteers shall meet the legal age requirements of the Commonwealth of Massachusetts, the state in which the Study is to be conducted.

Study Review. DFPCC shall conduct the Study with the prior approval and ongoing review of all appropriate and necessary review authorities and in accordance with all applicable federal, state and local laws and regulations. Principal Investigator shall provide Company with written evidence of review and approval of this Study by DFPCC's Institutional Review Board ("IRB") prior to the initiation of the Study and shall inform Company of the IRB's continuing review and approval of the Study promptly after such review takes place, which shall be at least once per year.

Study Review. Both cities shall have the opportunity to participate in the Feasibility Study review and provide comments on all deliverables. The cities agree to conduct the reviews and provide comments in a timely manner to assist the consultant in completing the Feasibility Study on the timeline designated in the contract.

Study Review. The Study shall be conducted by staff members of Institution under the direction of the Principal Investigator at Institution or elsewhere with the prior approval and ongoing review of all appropriate and necessary review authorities and in accordance with all applicable federal, state and local laws and regulations. The Study may also be subcontracted to other sites which have been approved by deCODE ("Approved Subcontractee"), provided that any such Approved Subcontractee agrees in writing to be bound by the terms of this Agreement. Principal Investigator shall provide deCODE with written evidence of review and approval of this Study by Institution's Institutional Review Board ("IRB") prior to the initiation of the Study and shall inform deCODE of the IRB's continuing review promptly after such review takes place, which shall be at least once per year.

Study Review. The PI shall conduct the STUDY at the KFSH&RC facilities with the prior approval and ongoing review of all appropriate and necessary review authorities and in accordance with all applicable local laws and regulations. PI shall obtain approval of this STUDY from the KFSH&RC Research Ethics Committee (“REC”) prior to initiation of the STUDY. Written evidence of review and approval of the STUDY by the KFSH&RC REC shall be maintained by PI and be made available to the Kingdom of Saudi Arabia’s Food and Drug Authority upon request. Continuing review by REC shall take place at least once per year, and documentation of continuing approval shall be maintained by PI.